16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Poly(amidoamine) Dendrimer–Methotrexate Conjugates: The Mechanism of Interaction with Folate Binding Protein

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Generation 5 poly(amidoamine) (G5 PAMAM) methotrexate (MTX) conjugates employing two small molecular linkers, G5-(COG-MTX) n , G5-(MFCO-MTX) n were prepared along with the conjugates of the G5-G5 (D) dimer, D-(COG-MTX) n , D-(MFCO-MTX) n . The monomer G5-(COG-MTX) n conjugates exhibited only a weak, rapidly reversible binding to folate binding protein (FBP) consistent with monovalent MTX binding. The D-(COG-MTX) n conjugates exhibited a slow onset, tight-binding mechanism in which the MTX first binds to the FBP, inducing protein structural rearrangement, followed by polymer–protein van der Waals interactions leading to tight-binding. The extent of irreversible binding is dependent on total MTX concentration and no evidence of multivalent MTX binding was observed.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Dendrimers and dendritic polymers in drug delivery.

          The unique properties of dendrimers, such as their high degree of branching, multivalency, globular architecture and well-defined molecular weight, make them promising new scaffolds for drug delivery. In the past decade, research has increased on the design and synthesis of biocompatible dendrimers and their application to many areas of bioscience including drug delivery, immunology and the development of vaccines, antimicrobials and antivirals. Recent progress has been made in the application of biocompatible dendrimers to cancer treatment, including their use as delivery systems for potent anticancer drugs such as cisplatin and doxorubicin, as well as agents for both boron neutron capture therapy and photodynamic therapy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications.

            Dendrimers are members of a versatile, fourth new class of polymer architecture (i.e. dendritic polymers after traditional linear, crosslinked and branched types). Typically, dendrimers are used as well-defined scaffolding or nanocontainers to conjugate, complex or encapsulate therapeutic drugs or imaging moieties. As a delivery vector, the dendrimer conjugate linker or spacer chemistry plays a crucial part in determining optimum drug delivery to disease sites by conserving active drug efficacy while influencing appropriate release patterns. This review focuses on several crucial issues related to those dendrimer features, namely the role of dendrimers as nanoscaffolding and nanocontainers, crucial principles that might be invoked for improving dendrimer cytotoxicity properties, understanding dendrimer cellular transport mechanisms and the exciting role of dendrimers as high-contrast MRI imaging agents. The review concludes with a brief survey of translational efforts from research and development phases to clinical trials that are actively emerging. 2010 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Thermodynamics of protein association reactions: forces contributing to stability.

                Bookmark

                Author and article information

                Journal
                Mol Pharm
                Mol. Pharm
                mp
                mpohbp
                Molecular Pharmaceutics
                American Chemical Society
                1543-8384
                1543-8392
                15 September 2015
                15 September 2014
                03 November 2014
                : 11
                : 11
                : 4049-4058
                Affiliations
                [1] Departments of Chemistry, Biomedical Engineering, §Physics, and the Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan , Ann Arbor, Michigan 48109, United States
                []Department of Chemistry, Calvin College , Grand Rapids, Michigan 49546, United States
                Author notes
                Article
                10.1021/mp500608s
                4224518
                25222480
                1fee35ab-c878-47a2-afad-adcaf40f2dbd
                Copyright © 2014 American Chemical Society

                This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

                History
                : 27 February 2014
                : 15 September 2014
                Funding
                National Institutes of Health, United States
                Categories
                Article
                Custom metadata
                mp500608s
                mp-2014-00608s

                Pharmacology & Pharmaceutical medicine
                pamam dendrimer,methotrexate,multivalent binding,polymer/protein interactions

                Comments

                Comment on this article